Micro TB Flashcards

1
Q

Species of

Mycobacteria :

A
❖ Mycobacterium tuberculosis complex
cause tuberculosis.
❖ Mycobacterium leprae causes
leprosy.
❖ Atypical Mycobacteria /
Mycobacteria other than
tuberculosis ( MOTT) cause
infections in immunosuppressed
patients.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mycobacterium

tuberculosis complex

A

1- M. tuberculosis (human type) very common
2- M. bovis (bovine type) (rare because of
pasteurization of milk)
3- M. Africanum
4- BCG strains (used for vaccination but in rare
cases it can cause TB in immunocompromised children)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Characteristics of the Genus Mycobacteria

A

Slim, rod shaped, non-motile, do not form spores
Do not stain by Gram stain because it Contain high
lipid conc. ( Mycolic acid ) in the cell wall which
resist staining.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mycobacterium stains

A

Ziehl-Neelsen ( Z-N ) and

Auramine staining

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathogenesis of Tuberculosis : 1

A

Mycobacteria acquired
by airborne droplet
reaches the alveolar
macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathogenesis of Tuberculosis : 2

A
This starts cell mediated
immune response; which
controls the
multiplication of the
organism but does not
kill it.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathogenesis of Tuberculosis : 3

A

Granuloma is formed,
organism lives in
dormant state (latent
tuberculosis infection).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pathogenesis of Tuberculosis : 4

A

Patient show evidence of
delayed cell mediated
immunity ( CMI ).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pathogenesis of Tuberculosis : 5

A

Disease results due to

destructive effect of CMI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Non-pulmonary TB :

A
TB of lymph nodes (cervical, mesenteric)
● TB meningitis (specifically in children, immunocompromised and old people)
● TB bone & joint
● TB of the genitourinary system.
● TB miliary (Blood and other organs.)
● TB of soft tissue (cold abscess):
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

TB of soft tissue (cold abscess

A

lacks inflammation with Caseation (shows no signs of inflammation)
Caseation: due to delayed hypersensitivity reaction. Contains many bacilli ,enzymes, O2,N2 intermediates,
necrotic center of granuloma with cheesy material

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Secondary TB Clinically: signs

A

fever, cough,
hemoptysis ,weight loss &
weakness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Source of secondary TB

A

Endogenous (reactivation of an
old TB)
Exogenous (reinfection with
new strain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Immunity to Tuberculosis

A

Cell-mediated immunity associated with delayed hypersensitivity reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Immunity to Tuberculosis detection and duration ?

A

Detected by tuberculin skin test

2-10 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tuberculin Skin Test NEGATIVE

A
➢ No previous infection
➢ Pre-hypersensitivity
stage
➢ Lost TB sensitivity
with loss of antigen
17
Q

Tuberculin Skin Test POSITIVE
1. >5mm induration
positive in:

A
1. >5mm
induration
positive in:
❖ Recent
contact with
active TB
❖ HIV or high
risk of HIV
❖ Chest X-ray
consistent
with healed
TB
18
Q

Tuberculin Skin Test POSITIVE
2. >10mm induration
positive in:

A
2. >10mm induration
positive in:
❖ IV drugs user
❖ HIV seronegative* patient
❖ medical conditions eg:
diabetes, malignancy
❖ Residents & employee at high
risk, and also patients from
country with high incidence
❖ Children < 4 years or exposed
to adult high risk group
19
Q

Tuberculin Skin Test POSITIVE
3. >15mm
induration
positive in

A
3. >15mm
induration
positive in:
❖ Any persons
including
those with no
risk of TB
20
Q

Laboratory Diagnosis of TB

1) Specimens

A
Pulmonary TB: 3 early morning(1)
sputum samples or bronchial lavage(2)
or gastric washing(3) (infants)
❖ TB Meningitis: Cerebrospinal fluid (
CSF).
❖ TB of the genitourinary system: 3
early morning urine.
❖ TB bone &amp; joint:Bone, joint aspirate.
❖ TB of lymph nodes: pus or tissues,
NOT swab.
❖ Repeat the sample.(4)
21
Q

Laboratory Diagnosis of TB Direct microscopy of

specimen

A

Z-N or (Auramine ) stain.

22
Q

Laboratory Diagnosis of TB 3) Culture

A

Culture: the gold standard.
Important for identification and
sensitivity.

23
Q

the gold standard.
Media used:

it contains ?

A

Media used:
Lowenstein-Jensen media (LJ).

Media contains: eggs,
asparagine, glycerol, pyruvate/
malachite green.*

24
Q

the gold standard. appearance :

A
Colonies appear in LJ media
after 2-8 weeks as eugenic,
raised, buff,
 adherent growth -enhanced by glycerol: (MTB)
-enhanced by pyruvate:
(M.bovis).
25
Laboratory Diagnosis of TB | Other media plus LJ media may be used:
Fluid media (middle Brook). Automated methods Measurement Interferon –gamma release assay (IGARAs) Molecular method
26
Automated methods
Bactec MGIT ( Mycobacteria Growth Indicator Test ).
27
Measurement Interferon –gamma release assay (IGARAs):
Measurement Interferon –gamma release assay (IGARAs): positive in latent TB IF-γ) secreted from sensitized lymphocytes challenged by the same mycobacterial proteins in a patient previously exposed to disease, will produce interferon gamma. Has a specific significance than tuberculin skin test. (increased risk of developing TB).
28
Molecular method
1-ProbTech ;detects nucleic acid directly from respiratory samples. 2-Xpert MTB/RIF detect nucleic acid and resistance to rifampicin . 3-PCR(polymerase chain reaction): molecular test directly from specimen (CSF).
29
Management of a TB case
❖Isolation for 10-14 days ( for smear positive cases i.e. > 1000 organisms / ml of sputum considered infectious case ). ❖ Triple regimen of therapy. Why? (combination of 3 or 4 drugs) 1. To prevent resistant mutants 2. To cover strains located at different sites of the lung 3. To prevent relapse ❖ Treatment must be guided by sensitivity testing.
30
Treatment of TB | First Line Treatment
``` ❖ Isoniazid (INH) ❖ Rifampicin (RIF) ❖ Ethambutol (E) ❖ Pyrazinamide (P) ❖ Streptomycin (S) ❖ Directly Observed Therapy (DOT). ```
31
Treatment of TB First Line Treatment For the first 2 months → the next 4-6 months →
For the first 2 months → INH + RIF + P or E +S For | the next 4-6 months → INH + RIF
32
Treatment of TB Second Line Treatment
``` ❖ PASA ( Para-Aminosalicylic acid). ❖ Ethionamide. ❖ Cycloserine. ❖ Kanamycin. ❖ Fluoroquinolones. ```
33
Prevention of TB
❖ Tuberculin testing of herds. ❖ Slaughter of infected animals. ❖ Pasteurization of milk to prevent bovine TB. ❖ Recognition of new cases. ❖ Prophylaxis with INH of contacts. ❖ Follow up cases. ❖ Immunization with BCG (live attenuated) to all newborns
34
Tb is transmitted by
inhaling Aerosols not droplets
35
waxy substance that prevents the Tb from being stained by gram stain.
Mycolic Acid
36
will increase the risk of Tb Meningitis
Not taking the BCG vaccine
37
can be given as an anaphylactic
INH
38
Which test can be used to predict the future of Tb?
Quantiferon because it’s specific